Dalus Capital Invests in Mexican Healthtech Eden

Gunderson Dettmer represented client Dalus Capital in participating in the $10 million financing of Eden, a Mexican healthtech specializing in generative AI for medical imaging and clinical diagnostics. Eden’s technology helps medical institutions produce, store and manage diagnostic images. Their AI tools help radiologists facilitate faster and more accurate diagnoses, reducing production costs and time. The company will use the new capital to drive research and development in AI, improve diagnostic tools and support its international expansion.

In the announcement of the transaction, Eden founder Julián Ríos Cantú said, “We are very good at mitigating costs involving cloud storage and image processing. This is a technical problem we know how to solve very well. So, when we offer these prices at such accessible rates, we can maintain margins to reinvest in functionalities and new modules.”

The Gunderson Dettmer deal team was led by Dan Green and included Daniel Gallo.

Companies
Dalus Capital
Eden